Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.
2.

Structure and transforming potential of the human cot oncogene encoding a putative protein kinase.

Miyoshi J, Higashi T, Mukai H, Ohuchi T, Kakunaga T.

Mol Cell Biol. 1991 Aug;11(8):4088-96.

3.

Structure, chromosome location, and expression of the human smooth muscle (enteric type) gamma-actin gene: evolution of six human actin genes.

Miwa T, Manabe Y, Kurokawa K, Kamada S, Kanda N, Bruns G, Ueyama H, Kakunaga T.

Mol Cell Biol. 1991 Jun;11(6):3296-306.

4.

Transcriptional regulatory elements in the 5' upstream and first intron regions of the human smooth muscle (aortic type) alpha-actin-encoding gene.

Nakano Y, Nishihara T, Sasayama S, Miwa T, Kamada S, Kakunaga T.

Gene. 1991 Mar 15;99(2):285-9.

PMID:
2022339
5.
6.
7.

Novel non-tumorigenic cell variants showing potentially different susceptibility to v-src-induced metastasis.

Enomoto T, Ayaki H, Nakamori S, Enomoto Y, Inoue H, Kakunaga T.

Jpn J Cancer Res. 1990 May;81(5):501-5.

8.

Hamster cell line suitable for transfection assay of transforming genes.

Higashi T, Sasai H, Suzuki F, Miyoshi J, Ohuchi T, Takai S, Mori T, Kakunaga T.

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2409-13.

9.

Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukemia.

Terada N, Miyoshi J, Kawa-Ha K, Sasai H, Orita S, Yumura-Yagi K, Hara J, Fujinami A, Kakunaga T.

Blood. 1990 Jan 15;75(2):453-7.

PMID:
1967219
11.

Protein kinase C activation in a 3T3 cell variant morphologically unresponsive to tumor-promoting phorbol esters.

Nakamori S, Enomoto T, Hayashi H, Kurita Y, Takai S, Mori T, Kakunaga T.

Biochem Int. 1989 Dec;19(6):1419-26.

PMID:
2635870
12.

A digital image processing system for quantitating dynamic morphology in cultured mammalian cells.

Tatsuka M, Jinno S, Owada MK, Kakunaga T.

Exp Cell Res. 1989 Dec;185(2):342-52. Erratum in: Exp Cell Res 1990 Apr;187(2):349.

PMID:
2599026
13.

Characterizations of two distinct Ca2+-dependent phospholipid-binding proteins of 68-kDa isolated from human placenta.

Hayashi H, Owada MK, Sonobe S, Kakunaga T.

J Biol Chem. 1989 Oct 15;264(29):17222-30.

14.

Cross-linking of lipocortin I and enhancement of its Ca2+ sensitivity by tissue transglutaminase.

Ando Y, Imamura S, Owada MK, Kakunaga T, Kannagi R.

Biochem Biophys Res Commun. 1989 Sep 15;163(2):944-51.

PMID:
2571332
15.

Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro.

Shiraishi T, Owada MK, Tatsuka M, Yamashita T, Watanabe K, Kakunaga T.

Cancer Res. 1989 May 1;49(9):2374-8.

16.

Quantitative measurement of cell motility associated with transformed phenotype.

Tatsuka M, Jinno S, Kakunaga T.

Jpn J Cancer Res. 1989 May;80(5):408-12.

19.

Differential requirements of gag and gamma-actin domains for transforming potential of Gardner-Rasheed feline sarcoma virus.

Miyoshi J, Miyoshi Y, Sasai H, Sakai N, Katsumata T, Kakunaga T.

J Virol. 1989 Mar;63(3):1174-80.

20.

The nucleotide sequence of a human smooth muscle alpha-actin (aortic type) cDNA.

Kamada S, Kakunaga T.

Nucleic Acids Res. 1989 Feb 25;17(4):1767. No abstract available.

21.

Identification of a site that mediates transcriptional response of the human beta-actin gene to serum factors.

Orita S, Makino K, Kawamoto T, Niwa H, Sugiyama H, Kakunaga T.

Gene. 1989 Jan 30;75(1):13-9.

PMID:
2470649
22.

DNA bending and binding factors of the human beta-actin promoter.

Kawamoto T, Makino K, Orita S, Nakata A, Kakunaga T.

Nucleic Acids Res. 1989 Jan 25;17(2):523-37.

24.

Altered expression of a third actin accompanying malignant progression in mouse B16 melanoma cells.

Taniguchi S, Sadano H, Kakunaga T, Baba T.

Jpn J Cancer Res. 1989 Jan;80(1):31-40.

25.

A simple and useful method for simultaneous screening of elevated levels of expression of a variety of oncogenes in malignant cells.

Nakamori S, Mukai H, Higashi T, Sasai H, Miyoshi J, Takai S, Mori T, Kakunaga T.

Jpn J Cancer Res. 1988 Dec;79(12):1311-7.

26.

cDNA cloning and sequence of a new type of actin in mouse B16 melanoma.

Sadano H, Taniguchi S, Kakunaga T, Baba T.

J Biol Chem. 1988 Nov 5;263(31):15868-71.

27.

An improved method of electroporation for introducing biologically active foreign genes into cultured mammalian cells.

Tatsuka M, Orita S, Yagi T, Kakunaga T.

Exp Cell Res. 1988 Sep;178(1):154-62.

PMID:
3409976
28.

Strong transcriptional promoter in the 5' upstream region of the human beta-actin gene.

Sugiyama H, Niwa H, Makino K, Kakunaga T.

Gene. 1988 May 15;65(1):135-9.

PMID:
3165082
29.
30.

Identification of the human beta-actin enhancer and its binding factor.

Kawamoto T, Makino K, Niwa H, Sugiyama H, Kimura S, Amemura M, Nakata A, Kakunaga T.

Mol Cell Biol. 1988 Jan;8(1):267-72.

31.

Molecular mechanisms of induction of transcription of beta-actin gene by tumour promoters and serum factors.

Kakunaga T, Makino K, Kawamoto T, Sugiyama H, Orita S, Niwa H.

IARC Sci Publ. 1988;(92):90-101. Review. No abstract available.

PMID:
3069734
32.

Protooncogene expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus as an indicator of the disease activity.

Deguchi Y, Hara H, Negoro S, Kakunaga T, Kishimoto S.

Clin Immunol Immunopathol. 1987 Dec;45(3):424-39.

PMID:
3677489
33.

A 32-kDa protein associated with phospholipase A2-inhibitory activity from human placenta.

Hayashi H, Owada MK, Sonobe S, Kakunaga T, Kawakatsu H, Yano J.

FEBS Lett. 1987 Nov 2;223(2):267-72.

34.

Isolation and characterization of three forms of 36-kDa Ca2+-dependent actin- and phospholipid-binding proteins from human placenta membrane.

Hayashi H, Sonobe S, Owada MK, Kakunaga T.

Biochem Biophys Res Commun. 1987 Jul 31;146(2):912-9.

PMID:
3619909
35.

[Malignant transformation and alteration of actin-related proteins].

Kakunaga T.

Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 2):1996-2001. Japanese.

PMID:
3606134
37.

Establishment of cell lines derived from ataxia telangiectasia and xeroderma pigmentosum patients with high radiation sensitivity.

Hashimoto T, Nakano Y, Owada MK, Kakunaga T, Furuyama J.

Mutat Res. 1986 Sep;166(2):215-20.

PMID:
3020400
38.

Differences in expression of a variant actin between low and high metastatic B16 melanoma.

Taniguchi S, Kawano T, Kakunaga T, Baba T.

J Biol Chem. 1986 May 5;261(13):6100-6.

39.

Growth stimulation by retinol apparently independent of EGF receptor.

Böning W, Kakunaga T, Emura M, Mohr U.

Exp Cell Res. 1986 Mar;163(1):255-60.

PMID:
3002830
40.

[Cytoskeleton of cancer cells].

Taniguchi S, Kakunaga T.

Nihon Rinsho. 1986 Feb;44(2):323-9. Review. Japanese. No abstract available.

PMID:
3517412
41.

Short-term assays to predict carcinogenicity. In-vitro assays that may be predictive of tumour-promoting agents.

Barrett JC, Kakunaga T, Kuroki T, Neubert D, Trosko JE, Vasiliev JM, Williams GM, Yamasaki H.

IARC Sci Publ. 1986;(83):287-302. Review. No abstract available.

PMID:
3305346
42.

Short-term assays to predict carcinogenicity. Mammalian cell transformation in culture.

Barrett JC, Kakunaga T, Kuroki T, Neubert D, Trosko JE, Vasiliev JM, Williams GM, Yamasaki H.

IARC Sci Publ. 1986;(83):267-86. Review. No abstract available.

PMID:
3305345
43.

Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T.

Proc Natl Acad Sci U S A. 1985 Sep;82(18):6133-7.

44.
45.

Intercellular communication capacity as a possible determinant of transformation sensitivity of BALB/c 3T3 clonal cells.

Yamasaki H, Enomoto T, Shiba Y, Kanno Y, Kakunaga T.

Cancer Res. 1985 Feb;45(2):637-41.

46.

Mutations in the neoplastically transformed human cells.

Kakunaga T.

Carcinog Compr Surv. 1985;9:205-16. No abstract available.

PMID:
4053075
47.

Critical review of the use of established cell lines for in-vitro cell transformation.

Kakunaga T.

IARC Sci Publ. 1985;67:55-73. Review. No abstract available.

PMID:
3913644
48.

Characterization of genomic poly(dT-dG).poly(dC-dA) sequences: structure, organization, and conformation.

Hamada H, Petrino MG, Kakunaga T, Seidman M, Stollar BD.

Mol Cell Biol. 1984 Dec;4(12):2610-21.

49.

Structure of a human smooth muscle actin gene (aortic type) with a unique intron site.

Ueyama H, Hamada H, Battula N, Kakunaga T.

Mol Cell Biol. 1984 Jun;4(6):1073-8.

50.

A mutation in actin associated with neoplastic transformation.

Kakunaga T, Leavitt J, Hamada H.

Fed Proc. 1984 May 15;43(8):2275-9.

PMID:
6201399

Supplemental Content

Loading ...
Support Center